The glaucoma treatment paradigm of topical medical therapy as first-line treatment is being re-evaluated as interventional approaches increase options for clinicians and patients. Sustained-release drug delivery (SRDD) and minimally invasive glaucoma surgery (MIGS) systems for glaucoma therapy are gaining ground as alternative to self-administered topical therapy. This webcast features the proceedings of a live CME symposium held on Monday, October 21, 2024, in which program chair Joseph Panarelli, MD, and panelists Eileen Bowden, MD, and Arsham Sheybani, MD, discuss the latest in SRDD and MIGS in the treatment of patients with open-angle glaucoma.
- Provider:MedEdicus, LLC
- Activity Link: https://courses.mededicus.com/content/case-discussions-interventional-glaucoma-best-practices-using-implants-and-migs-cme-webcast#group-tabs-node-course-default1
- Start Date: 2024-12-20 06:00:00
- End Date: 2024-12-20 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.25 hours
- Commercial Support: Source: AbbVie Inc - Amount: 60505.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest